B
Bio-Gene Technology Ltd
ASX:BGT
Bio-Gene Technology Ltd
ASX:BGT
Price:
0.035
AUD
-2.78%
Market Cap:
AU$10.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bio-Gene Technology Ltd
ASX:BGT
|
AU |
|
Subros Ltd
NSE:SUBROS
|
IN |
|
Arjo AB (publ)
STO:ARJO B
|
SE |
|
Payroll Inc
TSE:4489
|
JP |
|
EXEO Group Inc
TSE:1951
|
JP |
|
Nissin Foods Holdings Co Ltd
TSE:2897
|
JP |
|
A
|
Amer Sports Inc
NYSE:AS
|
FI |
|
EMV Capital PLC
LSE:EMVC
|
UK |
|
F
|
First Majestic Silver Corp
NYSE:AG
|
CA |
|
E
|
Eli Lilly and Co
XBER:LLY
|
US |
|
M
|
Metsa Board Oyj
OMXH:METSB
|
FI |
|
P
|
Porsche Automobil Holding SE
XBER:PAH3
|
DE |
|
IIFL Finance Ltd
NSE:IIFL
|
IN |
|
C
|
Cian Agro Industries & Infrastructure Ltd
BSE:519477
|
IN |
|
Luen Thai Holdings Ltd
HKEX:311
|
HK |
|
Focusrite PLC
LSE:TUNE
|
UK |
|
Indiabulls Real Estate Ltd
BSE:532832
|
IN |
Income Statement
Earnings Waterfall
Bio-Gene Technology Ltd
Bio-Gene Technology Ltd
Income Statement
Bio-Gene Technology Ltd
Bio-Gene Technology Ltd
Currency: AUD
| Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
1
+7%
|
1
+27%
|
1
+66%
|
1
-3%
|
1
-40%
|
1
+3%
|
1
+49%
|
1
-2%
|
1
-33%
|
1
+10%
|
1
+12%
|
1
-7%
|
1
-13%
|
0
-31%
|
1
+26%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Research & Development |
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(3)
-1%
|
(2)
+19%
|
(2)
+10%
|
(2)
-10%
|
(2)
-8%
|
(2)
-9%
|
(3)
-5%
|
(3)
-16%
|
(3)
-18%
|
(3)
+10%
|
(3)
+15%
|
(2)
+9%
|
(2)
+2%
|
(3)
-13%
|
(3)
-8%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(3)
+10%
|
(2)
+19%
|
(2)
+10%
|
(2)
-4%
|
(2)
-14%
|
(2)
-9%
|
(3)
-4%
|
(3)
-16%
|
(3)
-18%
|
(3)
+10%
|
(3)
+15%
|
(2)
+9%
|
(2)
+2%
|
(3)
-9%
|
(3)
+2%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(3)
N/A
|
(3)
+10%
|
(2)
+19%
|
(2)
+10%
|
(2)
-4%
|
(2)
-14%
|
(2)
-9%
|
(3)
-4%
|
(3)
-16%
|
(3)
-18%
|
(3)
+10%
|
(3)
+15%
|
(2)
+9%
|
(2)
+2%
|
(3)
-9%
|
(3)
+2%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
